The Activity of Members of the UDP-Glucuronosyltransferase Subfamilies UGT1A and UGT2B is Impaired in Patients with Liver Cirrhosis

被引:6
|
作者
Duthaler, Urs [1 ,2 ]
Bachmann, Fabio [1 ,2 ]
Ozbey, Agustos C. [3 ]
Umehara, Kenichi [3 ]
Parrott, Neil [3 ]
Fowler, Stephen [3 ]
Krahenbuhl, Stephan [1 ,2 ,4 ]
机构
[1] Univ Hosp Basel, Div Clin Pharmacol & Toxicol, CH-4031 Basel, Switzerland
[2] Univ Basel, Dept Biomed, Basel, Switzerland
[3] Roche Innovat Ctr Basel, Pharmaceut Sci, Roche Pharm Res & Early Dev, Basel, Switzerland
[4] Univ Hosp Basel, Dept Clin Res, Basel, Switzerland
关键词
DRUG-METABOLIZING-ENZYMES; ACETAMINOPHEN CLEARANCE; DOSE ADJUSTMENT; BASEL COCKTAIL; GLUCURONIDATION; PHARMACOKINETICS; DISPOSITION; DISEASE; IDENTIFICATION; TRANSPORTERS;
D O I
10.1007/s40262-023-01261-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and ObjectiveThe impact of liver cirrhosis on the activity of UDP-glucuronosyltransferases (UGTs) is currently not well characterized. We investigated the glucuronidation capacity and glucuronide accumulation in patients with liver cirrhosis.MethodsWe administered the Basel phenotyping cocktail (caffeine, efavirenz, flurbiprofen, omeprazole, metoprolol, midazolam) to patients with liver cirrhosis (n = 16 Child A, n = 15 Child B, n = 5 Child C) and n = 12 control subjects and obtained pharmacokinetic profiles of substrates and primary metabolites and their glucuronides.ResultsCaffeine and its metabolite paraxanthine were only slightly glucuronidated. The metabolic ratio (AUC(glucuronide)/AUC(parent), MR) was not affected for caffeine but decreased by 60% for paraxanthine glucuronide formation in Child C patients. Efavirenz was not glucuronidated whereas 8-hydroxyefavirenz was efficiently glucuronidated. The MR of 8-hydroxyefavirenz-glucuronide formation increased three-fold in Child C patients and was negatively correlated with the glomerular filtration rate. Flurbiprofen and omeprazole were not glucuronidated. 4-Hydroxyflurbiprofen and 5-hydroxyomeprazole were both glucuronidated but the corresponding MRs for glucuronide formation were not affected by liver cirrhosis. Metoprolol, but not alpha-hydroxymetoprolol, was glucuronidated, and the MR for metoprolol-glucuronide formation dropped by 60% in Child C patients. Both midazolam and its metabolite 1 '-hydroxymidazolam underwent glucuronidation, and the corresponding MRs for glucuronide formation dropped by approximately 80% in Child C patients. No relevant glucuronide accumulation occurred in patients with liver cirrhosis.ConclusionsDetailed analysis revealed that liver cirrhosis may affect the activity of UGTs of the UGT1A and UGT2B subfamilies according to liver function. Clinically significant glucuronide accumulation did not occur in the population investigated.
引用
收藏
页码:1141 / 1155
页数:15
相关论文
共 50 条
  • [1] The Activity of Members of the UDP-Glucuronosyltransferase Subfamilies UGT1A and UGT2B is Impaired in Patients with Liver Cirrhosis
    Urs Duthaler
    Fabio Bachmann
    Agustos C. Ozbey
    Kenichi Umehara
    Neil Parrott
    Stephen Fowler
    Stephan Krähenbühl
    Clinical Pharmacokinetics, 2023, 62 : 1141 - 1155
  • [2] Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus
    Strassburg, CP
    Strassburg, A
    Nguyen, N
    Li, Q
    Manns, MP
    Tukey, RH
    BIOCHEMICAL JOURNAL, 1999, 338 : 489 - 498
  • [3] Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus
    Strassburg, Christian P.
    Strassburg, Ahlke
    Nguyen, Nghia
    Li, Qing
    Manns, Michael P.
    Tukey, Robert H.
    Biochemical Journal, 1999, 338 (1-2): : 489 - 498
  • [4] Quantitative Analysis of UDP-Glucuronosyltransferase Ugt1a and Ugt2b mRNA Expression in the Rat Liver and Small Intestine: Sex and Strain Differences
    Kutsukake, Takaya
    Furukawa, Yoichi
    Ondo, Kyoko
    Gotoh, Saki
    Fukami, Tatsuki
    Nakajima, Miki
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (01) : 38 - 44
  • [5] Interactions Between Human UDP-Glucuronosyltransferase (UGT) 2B7 and UGT1A Enzymes
    Fujiwara, Ryoichi
    Nakajima, Miki
    Oda, Shingo
    Yamanaka, Hiroyuki
    Ikushiro, Shin-Ichi
    Sakaki, Toshiyuki
    Yokoi, Tsuyoshi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (01) : 442 - 454
  • [6] Quantitative Analysis of UDP-Glucuronosyltransferase (UGT) 1A and UGT2B Expression Levels in Human Livers
    Izukawa, Takeshi
    Nakajima, Miki
    Fujiwara, Ryoichi
    Yamanaka, Hiroyuki
    Fukami, Tatsuki
    Takamiya, Masataka
    Aoki, Yasuhiro
    Ikushiro, Shin-ichi
    Sakaki, Toshiyuki
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (08) : 1759 - 1768
  • [7] Telmisartan non-selectively inhibits UDP-glucuronosyltransferase (UGT) 1A and UGT2B proteins 3
    Knights, Kathleen M.
    Spencer, Shane M.
    Miners, John O.
    DRUG METABOLISM REVIEWS, 2011, 43 : 56 - 56
  • [8] Differential catalytic UDP-glucuronosyltransferase (UGT) activities in human liver and colon are not the result of differences in UGT1A protein expression
    Strassburg, CP
    Nguyen, N
    Manns, MP
    Tukey, RH
    HEPATOLOGY, 1998, 28 (04) : 382A - 382A
  • [9] Expression and regulation of UDP-glucuronosyltransferases from the UGT1A and UGT2B families in mice with altered PXR activity
    Radominska-Pandya, A
    Xie, W
    Heydel, JM
    DRUG METABOLISM REVIEWS, 2003, 35 : 56 - 56
  • [10] Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation
    Kurita, Ayumi
    Miyauchi, Yuu
    Ikushiro, Shin'ichi
    Mackenzie, Peter I.
    Yamada, Hideyuki
    Ishii, Yuji
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 361 (02): : 199 - 208